This panel included cell lines representing all four molecular subtypes of cutaneous melanoma with driver mutations in the BRAF, NRAS, or NF1 genes and a fourth triple wild-type subtype, in which none of these genes are mutated [20]. This evidence concerns the gene BRAF and cutaneous melanoma.